BIO is Bio-Rad Laboratories, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $384.80. Market cap: $10.37B. Capital Quality Rank: 82/100 — Elite compounder.
Stock snapshot
| Price | $384.80 |
| Market cap | $10.37B |
| Sector | Healthcare |
| Exchange | NYQ |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 82 / 100 · Elite compounder |
| ROIC (TTM) | 2.1% |
| Revenue CAGR (3y) | -2.7% |
| Shareholder buyback yield | 1.75% |
| Altman Z-score zone | Safe |
About BIO
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Related non-dividend companies
Other non-dividend stocks investors research alongside BIO. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is BIO's current stock price?
BIO (Bio-Rad Laboratories, Inc.) is currently trading at $384.80.
Does BIO pay a dividend?
BIO (Bio-Rad Laboratories, Inc.) does not currently pay a regular dividend.
What is BIO's Capital Quality Rank?
BIO has a Capital Quality Rank of 82/100 — Elite compounder. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track BIO in DiviDrip
Add BIO to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search BIO and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-08-31. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.
